Sp1 facilitates continued HSV-1 gene expression in the absence of key viral transactivators.

Autor: Sodroski CN; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.; Program in Virology, Harvard Medical School, Boston, Massachusetts, USA., Oh HS; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA., Chou S-F; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA., Knipe DM; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.; Program in Virology, Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: MBio [mBio] 2024 Mar 13; Vol. 15 (3), pp. e0347923. Date of Electronic Publication: 2024 Feb 13.

Tissue-Resident-Memory CD8 ⁺ T Cells Bridge Innate Immune Responses in Neighboring Epithelial Cells to Control Human Genital Herpes.

Autor: Peng T; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Phasouk K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Sodroski CN; Department of Microbiology and Virology Program, Blavatnik Institute, Harvard Medical School, Boston, MA, United States., Sun S; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States., Hwangbo Y; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States., Layton ED; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States., Jin L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Klock A; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States., Diem K; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Magaret AS; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.; Department of Biostatistics, University of Washington, Seattle, WA, United States., Jing L; Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States., Laing K; Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States., Li A; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States., Huang ML; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Mertens M; Department of Microbiology and Virology Program, Blavatnik Institute, Harvard Medical School, Boston, MA, United States., Johnston C; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.; Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States., Jerome KR; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Koelle DM; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.; Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States.; Department of Global Health, University of Washington School of Medicine, Seattle, WA, United States.; Benaroya Research Institute, Seattle, WA, United States., Wald A; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.; Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States.; Department of Epidemiology, University of Washington, Seattle, WA, United States., Knipe DM; Department of Microbiology and Virology Program, Blavatnik Institute, Harvard Medical School, Boston, MA, United States., Corey L; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.; Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States.; Department of Global Health, University of Washington School of Medicine, Seattle, WA, United States., Zhu J; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.; Institute for Stem Cell & Regenerative Medicine, University of Washington, Seattle, WA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2021 Sep 06; Vol. 12, pp. 735643. Date of Electronic Publication: 2021 Sep 06 (Print Publication: 2021).

A digenic human immunodeficiency characterized by IFNAR1 and IFNGR2 mutations.

Autor: Hoyos-Bachiloglu R; Division of Immunology, Boston Children's Hospital and Department of Pediatrics, and., Chou J; Division of Immunology, Boston Children's Hospital and Department of Pediatrics, and., Sodroski CN; Department of Microbiology and Immunobiology and Harvard Program in Virology, Harvard Medical School, Boston, Massachusetts, USA., Beano A; Division of Immunology, Boston Children's Hospital and Department of Pediatrics, and., Bainter W; Division of Immunology, Boston Children's Hospital and Department of Pediatrics, and., Angelova M; Department of Microbiology and Immunobiology and Harvard Program in Virology, Harvard Medical School, Boston, Massachusetts, USA., Al Idrissi E; Department of Pediatrics, King Fahad Medical City, Riyadh, Saudi Arabia., Habazi MK; Department of Pediatrics, King Fahad Medical City, Riyadh, Saudi Arabia., Alghamdi HA; Department of Pediatrics, King Fahad Medical City, Riyadh, Saudi Arabia., Almanjomi F; Department of Pediatrics, King Fahad Medical City, Riyadh, Saudi Arabia., Al Shehri M; Department of Pediatrics, King Fahad Medical City, Riyadh, Saudi Arabia., Elsidig N; Department of Pediatrics, King Fahad Medical City, Riyadh, Saudi Arabia., Alaa Eldin M; Department of Pediatrics, King Fahad Medical City, Riyadh, Saudi Arabia., Knipe DM; Department of Microbiology and Immunobiology and Harvard Program in Virology, Harvard Medical School, Boston, Massachusetts, USA., AlZahrani M; Department of Pediatrics, King Fahad Medical City, Riyadh, Saudi Arabia., Geha RS; Division of Immunology, Boston Children's Hospital and Department of Pediatrics, and.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2017 Dec 01; Vol. 127 (12), pp. 4415-4420. Date of Electronic Publication: 2017 Nov 06.